Both in Pharmaceuticals
Maravai LifeSciences Holdings vs Janux Therapeutics
Over the past year MRVI returned +143.2% and JANX returned −41.7%; their daily moves had a correlation of 0.12.
MRVI +143.2% JANX −41.7%Growth of $1, one year, split-adjusted
| Metric | MRVI | JANX |
|---|---|---|
| Price | $7.06 | $17.02 |
| Market cap | $1.05B | $1.04B |
| Today | −8.61% | −6.38% |
| 1 month | −5.0% | −5.0% |
| 6 months | +79.1% | +17.1% |
| Year to date | +117.1% | +23.3% |
| 1 year | +145.8% | −37.0% |
| Revenue growth (YoY) | +8.5% | — |
| Gross margin | 40.1% | 100.0% |
| Net margin | −24.1% | −214.0% |
| P/E (TTM) | — | — |
| Price / sales | 5.0× | 43.4× |
| Net cash | -$106.6M | $970.9M |
| Dividend yield | — | — |
| Volatility (60d) | 88.4% | 49.7% |
| Short % of float | 10.7% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).